These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1124318)

  • 21. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F; Theiss W
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
    Lillie MA; Mink IB
    Am J Obstet Gynecol; 1974 Jun; 119(3):406-10. PubMed ID: 4827381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral contraceptives and blood platelets].
    Davenas E; Ciavatti M; Poitevin B; Aubin M
    Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems of the effect of peroral contraceptives on intravascular coagulation].
    Krislo V; Mach M; Labuda V; Falckráb E; Bahorecz T; Beláková L
    Cesk Gynekol; 1982 Nov; 47(9):646-9. PubMed ID: 7151192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of platelet factor 3 in the hypercoagulability induced by pregnancy and oral contraceptives.
    Renaud S; Gautheron P
    Thromb Diath Haemorrh; 1973 Nov; 30(2):299-306. PubMed ID: 4797961
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term and long-term intra-individual variations and critical differences of coagulation parameters.
    Costongs GM; Bas BM; Janson PC; Hermans J; Brombacher PJ; van Wersch JW
    J Clin Chem Clin Biochem; 1985 Jul; 23(7):405-10. PubMed ID: 4045388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Side effects of the oral contraceptive Ovosiston on the blood coagulation system].
    Carol W; Klinger G; Hempel E; Starker K; Quent P
    Zentralbl Gynakol; 1970 Dec; 92(50):1641-50. PubMed ID: 4099364
    [No Abstract]   [Full Text] [Related]  

  • 30. Fibrinolytic response in women on low-dose oral contraceptive.
    Ishak R; Ahmad R; Gudum HR; Hassan K; Ang ES
    Malays J Reprod Health; 1992 Jun; 10(1):7-11. PubMed ID: 12345026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood coagulation values of sheep.
    Gajewski J; Povar ML
    Am J Vet Res; 1971 Mar; 32(3):405-9. PubMed ID: 5547008
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemocoagulation factors in contraception induced by Antigest].
    Misinger I; Krobová I; Hermanská Z
    Cesk Gynekol; 1967 Apr; 32(3):197-200. PubMed ID: 6082989
    [No Abstract]   [Full Text] [Related]  

  • 34. Interleukin-6 and antiphospholipid antibodies in women with contraceptive-related thromboembolic disease.
    Salobir B; Sabovic M
    Obstet Gynecol; 2004 Sep; 104(3):564-70. PubMed ID: 15339770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen after massive haemorrhage. Studies on coagulation and fibrinolysis of blood and lymph in dogs.
    Leandoer L
    Acta Chir Scand Suppl; 1968; 390():1-20. PubMed ID: 5275171
    [No Abstract]   [Full Text] [Related]  

  • 36. Physiological and psychological effects of vitamins E and B6 on women taking oral contraceptives.
    Applegate WV; Forsythe A; Bauernfeind JB
    Int J Vitam Nutr Res; 1979; 49(1):43-50. PubMed ID: 376467
    [No Abstract]   [Full Text] [Related]  

  • 37. Reducing the risk of oral contraceptive-induced thrombosis.
    Pizzo SV
    Drug Ther (NY); 1981 Sep; 11(9):101-8. PubMed ID: 12263495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of thromboembolic side effects of oral contraceptives: methodologic recommendations].
    Póka R; Balogh I; Ajzner E; Nagy IG
    Orv Hetil; 1998 Apr; 139(14):815-8. PubMed ID: 9569728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of cytostatic combination therapy with vincristine sulphate and iphosphamide on blood coagulation].
    Neidhardt B; Hartwich G
    Dtsch Med Wochenschr; 1975 Feb; 100(9):409-12. PubMed ID: 1116466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.